Listed by the USPTO as SANG, HONG
Tech Center 1600 • Art Units: 1643 1645 1646
This examiner grants 55% of resolved cases
SANG, HONG examines in Tech Center 1600 and Art Unit 1643. The record covers 934 resolved cases, with a 54.9% allowance rate and a 62.8% interview lift. Median time to allowance is 1274 days. The substantial case volume makes the interview measure particularly relevant for practitioners deciding how prominently to feature examiner interaction in prosecution planning.
Listed companies include Janssen Pharmaceuticals Inc., Chugai Seiyaku Kabushiki Kaisha, and The United States of America, as represented by the Secretary, Department of Health and Human Services. Listed firms are Hamilton, Brook, Smith & Reynolds, P.C., STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C., and BROWNSTEIN HYATT FARBER SCHRECK, LLP. These participants indicate established activity across pharmaceutical and public-sector matters in the docket.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17774685 | Anti-TIGIT Antibodies and Uses Thereof | Non-Final OA | Merck Patent GmbH |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy54.9% of resolved applications examined by Hong Sang were allowed (934 resolved cases), compared with 41.5% across Art Unit 1643 over the last five years.
This examiner's interview lift is +62.8 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Hong Sang took 1,274 days on average from filing to allowance.
Hong Sang examines applications in Art Unit 1643 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
